Industrializing Quantitative Systems Pharmacology (QSP): Why now and how.
What does it take to industrialize QSP? What is the right mix of technology and…
Danielle Pillsbury2024 年 1 月 9 日
MedCity News | How the IRA Has Created a New Environment for Biosimilars
By Maximillian Vargas and Caitlin Verrilli As IRA provisions are activated, the law’s impact on…
Certara2024 年 1 月 5 日
Clinical Research News | Trendspotting: What’s Coming for Clinical Trials and Research in 2024
By Clinical Research Team We spoke with leaders and experts in the Clinical Research community…
Certara2024 年 1 月 5 日
Bio-IT World | Trendspotting: What’s Coming for Biotech in 2024
By Bio-IT World Team To kick off the New Year, we spoke with leaders and…
Certara2024 年 1 月 5 日
Physiologically Based Pharmacokinetic modelling of drugs in pregnancy: A mini-review on availability and limitations
This mini-review provides a concise and comprehensive overview of the pregnancy PBPK field and identify…
Jim Gallagher2024 年 1 月 3 日
A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy
This comprehensive review exposes gaps in current knowledge of phase II enzyme and drug transporter…
Jim Gallagher2024 年 1 月 3 日
Total and Free Blood and Plasma Concentration Changes in Pregnancy for Medicines Highly Bound to Plasma Proteins: Application of Physiologically Based Pharmacokinetic Modelling to Understand the Impact on Efficacy
For drugs highly bound to plasma proteins, changes in concentrations of free drug may have…
Jim Gallagher2024 年 1 月 3 日
Bridging the Gap: Integrating Pharmacometrics with Quantitative Systems Pharmacology (QSP) for Smoother Clinical Phase Transitions
借助行业领导者的真知灼见，掌握临床阶段的转换！Join Piet van der Graaf, SVP…
Danielle Pillsbury2024 年 1 月 2 日
Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials
A FRIENDS OF CANCER RESEARCH WHITE PAPER The article explores the complex landscape of determining…
Jim Gallagher2023 年 12 月 19 日
